Form 4: Modular Medical Director Acquires Stock Options

Director Morgan C. Frank acquired stock options in Modular Medical, Inc. on December 31, 2024.

Summary

• Morgan C. Frank, a director of Modular Medical, Inc., acquired options to purchase common stock on December 31, 2024.
• The options were granted under the company's Outside Director Compensation Plan.
• A total of 9,375 options were acquired, with an exercise price of $1.39 per share.
• The options are fully vested and exercisable as of the grant date, December 31, 2024, and expire on December 31, 2034.

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants to a director. It is neither particularly positive nor negative, but it does indicate that a director has a vested interest in the company's performance.

Positives

• The acquisition of options by a director may indicate confidence in the company's future performance.
• The options are fully vested and exercisable immediately, suggesting a long-term commitment from the director.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders make transactions in their company's securities. It is a routine disclosure and does not indicate any specific industry trend.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies as part of their compensation packages.
• The vesting and exercise terms of these options are typical for director compensation plans.
• The reporting of these transactions via SEC Form 4 is a standard regulatory requirement.

Stakeholder Impact

• The stock option grant may be viewed positively by shareholders as it aligns the director's interests with those of the company.

Key Dates

Keywords

stock options, director, insider trading, beneficial ownership, Modular Medical, MODD